Vascular Dementia Market is Projected to Boost at a Moderate Growth Rate of 4.5% During the Forecast Period (2026-2036)
One daysingle sourceOne outlet reported this themselves - 1 of the 2 reports ran its copy.
After publishing: 1 URL changed1 change
- prnewswire.comseen 15 Aug, 05:58URL changed
All 2 reports on Tue, 11 August 2026
What it is about
Resverlogix ApabetaloneAnnovis BioAparna ThakurShruti ThakurFite BiopharmaMerz PharmaEli LillyApabetalone ResverlogixNeuraltus PharmaceuticalsJohnson JohnsonNeurim PharmaceuticalsPfizerAcadia PharmaceuticalsBausch Health RifaximinBristol Myers SquibbSuven Life SciencesDrug Development ActivitiesDelveinsight Business ResearchBausch HealthResverlogix Corporation
Who published it, and when
original reportcopyfirst to report
prnewswire.com
finanznachrichten.de
11 Aug, 14:31over 2 hours11 Aug, 16:36
How it spread - 1 original report, 1 reprint
Tue, 11 August 2026
1 report- finanznachrichten.de16:36first to report
The vascular dementia market is expected to increase due to the rising prevalence of the disease driven by the aging global population, the growing incidence of stroke and other vascular risk
1 reprint
- prnewswire.com11 Aug, 14:31their copy